Videos VIDEO: ZUMA1 trial of CD19 CAR T cells for aggressive NHL SHARE Facebook Twitter tweet July 6, 2017 (ecancer) Dr Lin speaks with ecancer at EHA 2017 about clinical and biologic outcomes in patients with refractory aggressive Non-Hodgkin Lymphoma (NHL) treated with CAR T cell therapy. RELATED ARTICLESMORE FROM AUTHOR Video of a T-cell attacking a cancer cell. The Goal of Armored CAR T Cells VIDEO: CAR T-cells for CLL